Barclays PLC Beauty Health CO Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Beauty Health CO stock. As of the latest transaction made, Barclays PLC holds 106,103 shares of SKIN stock, worth $164,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares

106,103

Previous 106,103 -0.0%

Holding current value

$164,459

Previous $153,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$1.12 - $2.2 $82,236 - $161,535	73,425 Added 224.69%	106,103 $153,000
Q2 2024 Aug 14, 2024	SELL	$1.77 - $4.28 $165,417 - $399,991	-93,456 Reduced 74.09%	32,678 $63,000
Q1 2024 May 15, 2024	SELL	$2.39 - $4.53 $31,961 - $60,579	-13,373 Reduced 9.59%	126,134 $560,000
Q4 2023 Feb 15, 2024	BUY	$1.39 - $5.86 $62,855 - $264,989	45,220 Added 47.96%	139,507 $433,000
Q3 2023 Nov 07, 2023	SELL	$5.47 - $8.78 $278,685 - $447,323	-50,948 Reduced 35.08%	94,287 $567,000
Q2 2023 Aug 03, 2023	SELL	$7.77 - $13.7 $423,449 - $746,622	-54,498 Reduced 27.29%	145,235 $1.22 Million
Q1 2023 May 04, 2023	BUY	$9.22 - $13.3 $461,590 - $665,851	50,064 Added 33.45%	199,733 $2.52 Million
Q4 2022 Feb 13, 2023	SELL	$8.39 - $13.4 $1.73 Million - $2.76 Million	-206,158 Reduced 57.94%	149,669 $1.36 Million
Q3 2022 Nov 03, 2022	BUY	$10.35 - $15.27 $1.66 Million - $2.45 Million	160,327 Added 82.01%	355,827 $4.2 Million
Q2 2022 Aug 12, 2022	SELL	$10.6 - $17.48 $6.43 Million - $10.6 Million	-606,914 Reduced 75.64%	195,500 $2.51 Million
Q1 2022 May 16, 2022	BUY	$12.24 - $24.07 $9.82 Million - $19.3 Million	802,414 New	802,414 $13.5 Million

Others Institutions Holding SKIN

# of Institutions

128

Shares Held

54.8M

Call Options Held

3.71M

Put Options Held

394K

View Full List

About Beauty Health Co

Ticker SKIN
Exchange NASDAQ
Sector Consumer Defensive
Industry Household & Personal Products
Shares Outstandng 150,887,008
Market Cap $234M
Description
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Hydra...

More about SKIN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account